Rankia España Rankia Argentina Rankia Brasil Rankia Chile Rankia Colombia Rankia Czechia Rankia Deutschland Rankia France Rankia Indonesia Rankia Italia Rankia Magyarország Rankia México Rankia Netherlands Rankia Perú Rankia Polska Rankia Portugal Rankia Romania Rankia Türkiye Rankia United Kingdom Rankia USA
Acceder

Farmas USA

135K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
14.744 / 16.979
#117946

Re: Farmas USA

Justo miraba eso! olemos la sangre o las rosas jajajaja
Salto por que la VI se ha disparado

Solo se que no se nada.

#117947

Re: Farmas USA

Se sabe por qué?

Si te sientas en la mesa y no descubres al "primo" es que lo eres tú.

#117948

Re: Farmas USA

 In this, probably the expected FDA nod for a CV benefit claim for Vascepa (icosapent ethyl). The agency's action date is December 28. 

AMRN

Solo se que no se nada.

#117950

Re: Farmas USA

No se sabe xo he leído que se ha detectado actividad call alta hoy. 
Puede ser decisión del label x parte de la FDA adelantada w se esperaba xa 28 pero siendo estas fechas se hayan adelantado ...
#117951

Re: Farmas USA

Amarin up 7% after positive Ad Com vote on CV claim for Vascepa

Nov. 15, 2019 8:09 AM ET|About: Amarin Corporation plc (AMRN)|By: Douglas W. House, SA News Editor 
Amarin (NASDAQ:AMRN) is up 7% premarket on robust volume after yesterday's positive vote from an FDA advisory committee backing a CV benefit claim for Vascepa (icosapent ethyl).

Amarin's Vascepa to become 'blockbuster,' analyst says in maintaining Buy


In a "conservative base case" where the drug is approved for secondary prevention along with additional patient qualifications, Vascepa could achieve sales "north of $2B a year" by 2025, Weinstein says in maintaining his Buy rating and $23 price target on the shares.
https://seekingalpha.com/news/3521887-amarins-vascepa-to-become-blockbuster-analyst-says-in-maintaining-buy
--------------

Amarin shares halted pending news

Dec. 13, 2019 1:10 PM ET|About: Amarin Corporation plc (AMRN)|By: Douglas W. House, SA News Editor 
Nasdaq has suspended trading in Amarin (AMRN +4.9%) pending the release of news. In this, probably the expected FDA nod for a CV benefit claim for Vascepa (icosapent ethyl). The agency's action date is December 28
.https://seekingalpha.com/news/3526234-amarin-shares-halted-pending-news
#117952

Re: Farmas USA

Otras de que replican a AMRN

Acasti Pharma Inc. (ACST)      Market Cap | 149.32M
2.025+0.275 (+15.7143%)
As of 2:35PM EST. Market open.
------------
Matinas BioPharma Holdings, Inc. (MTNB
1.8201+0.2401 (+15.1962%)       Market Cap | 247.89M
As of 2:37PM EST. Market open.
--



Guía Básica
Brokers destacados